Indacaterol/Glycopyrronium/Mometasone fixed dose combination for uncontrolled asthma
Expert Rev Respir Med. 2021 Nov 30. doi: 10.1080/17476348.2021.2011222. Online ahead of print.ABSTRACTINTRODUCTION: Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on ...
Source: Expert Review of Respiratory Medicine - November 30, 2021 Category: Respiratory Medicine Authors: Corrado Pelaia Claudia Crimi Nunzio Crimi Luisa Ricciardi Nicola Scichilone Giuseppe Valenti Ornella Bonavita Stefano Andaloro Paolo Morini Andrea Rizzi Girolamo Pelaia Source Type: research
